株価と価値の比較
- Price
- $941.95
- Fair value
- $410.01
- Potential value
- $495.63
- As of
- 2026-09-04
投資仮説が成立する理由
Delivering the FY2026-FY2027 revenue runway while preserving cash-backed profit could extend growth beyond the Base-case fade.
見方を変える要因
Provider-adjusted normalized net margin remains below 9% by FY2028.
Sell. Ordinary investors should avoid new exposure and reduce existing holdings because the report-date price stands well above our Fair value and Potential value.
The report was prepared at $941.95 on 2026-09-04. Fair value is $410.01 and Potential value is $495.63 as of 2026-09-08, implying -56.47% to Fair value.1
The main risk is normalized net margin below 9% by FY2028. Weaker pricing or mix would reduce earnings and operating cash, while a lower valuation multiple would deepen the loss.